TrialAnnals of oncology : official journal of the European Society for Medical Oncology2022

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.

V Subbiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.